The gap between the drug policies of both countries seems unbridgeable. The Dutch policy is a thorn in the side of the United States and vice versa.
Within a committee of experts, the idea arises to seek cooperation now, specifically around scientific research. Collaboration in two such different contexts creates solid knowledge.
Trailblazing
As secretary of the committee, I am the trailblazer in the background. I take care of the contacts and the meetings. With experts from both parties, I design the cooperation procedure. Navigating such politically and administratively complicated waters requires a lot of strategic thinking and discretion.
The result
Research programmers from both parties sign an agreement. Both organizations then finance research and fruitful exchange meetings. The CEOs of both parties see this bilateral collaboration as a great success. The research yields valuable knowledge, the collaboration improves the relationship.